| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,314,504,004 |
|
|
|
Indirect Value
|
$5,792,390 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,320,296,394 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -4.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-12 |
4 |
B |
$9.15 |
$164,691 |
D/D |
17,999 |
36,984,179 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-11 |
4 |
B |
$9.36 |
$843,504 |
D/D |
90,118 |
36,966,180 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-08 |
4 |
B |
$9.54 |
$1,112,898 |
D/D |
116,656 |
36,876,062 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-07 |
4 |
B |
$9.19 |
$687,890 |
D/D |
74,852 |
36,759,406 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-06 |
4 |
OE |
$5.95 |
$59,101 |
D/D |
9,933 |
36,601,741 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-06 |
4 |
B |
$9.06 |
$750,286 |
D/D |
82,813 |
36,684,554 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-05 |
4 |
B |
$9.34 |
$616,636 |
I/I |
66,021 |
351,565 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-04 |
4 |
B |
$10.38 |
$280,260 |
I/I |
27,000 |
285,544 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-04 |
4 |
OE |
$10.66 |
$430,099 |
D/D |
40,347 |
36,591,808 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-01 |
4 |
B |
$9.07 |
$413,592 |
I/I |
45,600 |
258,544 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-30 |
4 |
B |
$9.06 |
$1,385,673 |
I/I |
152,944 |
212,944 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.21 |
$552,600 |
I/I |
60,000 |
60,000 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.44 |
$1,497,184 |
D/D |
158,600 |
36,551,461 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,392,861 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-28 |
4 |
B |
$8.98 |
$1,117,085 |
D/D |
124,397 |
36,391,194 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-17 |
4 |
B |
$6.09 |
$123,470 |
D/D |
20,241 |
36,266,797 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-07 |
4 |
OE |
$5.95 |
$78,927 |
D/D |
13,265 |
36,246,556 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-08-25 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,233,291 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-07-25 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,231,624 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-07-07 |
4 |
OE |
$2.14 |
$150,012 |
D/D |
67,133 |
36,229,957 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-07-05 |
4 |
OE |
$2.14 |
$139,100 |
D/D |
65,000 |
36,162,824 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2023-06-14 |
4 |
OE |
$2.05 |
$166,101 |
I/I |
81,025 |
492,069 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2023-06-14 |
4 |
OE |
$2.05 |
$11,650,484 |
D/D |
5,683,163 |
36,097,824 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2023-05-09 |
4 |
B |
$6.51 |
$65,249,320 |
D/D |
10,022,937 |
30,414,661 |
3.92 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
B |
$1.05 |
$395,314,374 |
D/D |
376,489,880 |
552,354,161 |
2.81 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
